CORRECTIONS

Abstract

Corrections| March 01 2004 CORRECTIONS Am J Crit Care (2004) 13 (2): 101. https://doi.org/10.4037/ajcc2004.13.2.101 Connected Content Errata: American Journal of Critical Care: The Significance of Hypothermia in Preserving Ischemic Myocardium Errata: American Journal of Critical Care: B-Type Natriuretic Peptide: A Diagnostic, Prognostic, and Therapeutic Tool in Heart Failure Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Tools Icon Tools Cite Icon Cite Get Permissions Citation CORRECTIONS. Am J Crit Care 1 March 2004; 13 (2): 101. doi: https://doi.org/10.4037/ajcc2004.13.2.101 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAmerican Journal of Critical Care Search Advanced Search Regarding the article titled “The Significance of Hypothermia in Preserving Ischemic Myocardium” (Am J Crit Care. 2004;13:79–84), the title of the article appeared correctly in the article itself but contained a typographical error (correct spelling is “Hypothermia”) in the Table of Contents and on the cover. We regret the error. On page 55 of the article titled “B-Type Natriuretic Peptide: A Diagnostic, Prognostic, and Therapeutic Tool in Heart Failure” (Am J Crit Care. 2004;13:46–55), an error appeared in the CE test, question 9. It should have read as follows: 9. Which of the following is the recommended dose of nesiritide (Natrecor), as a therapeutic agent for use in heart failure, after an initial intravenous bolus? The entire CE test is reprinted on page 171 of this issue of the Journal. View Original Article You do not currently have access to this content.